穴位埋线治疗慢性阻塞性肺疾病稳定期临床疗效观察

目的观察穴位埋线治疗慢性阻塞性肺疾病（COPD）稳定期的临床疗效。方法将COPD稳定期患者随机分为治疗组（30例）和对照组（30例），治疗组予以穴位埋线加西医常规治疗；对照组予以西医常规治疗。两组均治疗6个月。比较两组治疗前后6个月内COPD急性加重（AECOPD）次数、中度以上AECOPD次数、中医证候积分、圣乔治呼吸问卷（SGRQ）评分、第1秒用力呼气容积（FEV1）、安全性指标等。结果治疗组治疗开始后6个月期间，AECOPD次数、中度以上AECOPD次数均较治疗前减少（P〈0．01）；与对照组比较，治疗组治疗开始后6个月期间的AECOPD次数减少（P〈0．05）；治疗组治疗后中医证候总积分、咳嗽、胸闷症状积分均低于对照组，差异有统计学意义（P〈0．05，P〈0．01）；治疗组治疗开始后6个月SGRQ的症状、影响评分及总分较治疗前有所改善（P〈0．05），而对照组治疗后仅SGRQ的影响评分有所改善（P〈0．05）；两组治疗前后肺功能尤其是FEV，均无明显好转（P〉0．05）。结论穴位埋线治疗能减少COPD稳定期AECOPD次数，改善咳嗽、胸闷等症状，提高生活质量，且安全可靠。

Clinical Observation of Acupoint Thread-Embedding Therapy for Stable Chronic Obstructive Pulmonary Disease

Objective To evaluate the effects of acupoint thread-embedding therapy for stable chronic obstructive pulmonary disease （COPD）. Methods Sixty stable COPD patients were randomly divided into two groups： 30 patients in treatment group were treated with acupoint thread-embedding therapy and conventional medicine, while 30 cases in control group were treated with conventional medicine alone, both for six months. Indexes including frequencies of AECOPD and moderate or severe AECOPD, scores in TCM symptoms, St George＇s respiratory questionnaire（SGRQ） and FEV1 were observed. Results After 6-month follow-up, the treatment group had less AECOPD than before（2.30 ±0.29 vs 1.08 ±0.17, P 〈0.01 ）, which was also less than the control group after treatment（ 1.08 ±0.17 vs 1.59±0.18, P 〈0.05 ）. The treatment group also had less AECOPD in moderate or above than before（ 1.81±0.21 vs 1.04±0.16, P 〈0.01 ）. Both groups had satisfactory scores in TCM symptoms and the treatment group had better sores than the control group （3.40 ±0.36 vs 4.50±0.35, P 〈0.05 ）. In the aspects of cough, sputum and chest stuffiness, the patients in the treatment group recovered better than the ones in the control group（P 〈0.05）. Both of the groups bad better SGRQ scores, with the better scores in the aspects of symptom, influence and total aspects in the treatment group（P 〈0.05）, while the control group improved only in the aspect of influence（ P 〈0.05 ）. The pulmonary function（ FEV1 ） in both groups didn＇ t improve（ P 〉0.05 ）. Conclusion Integrated treatment of aeupoint thread-embedding and conventional medicine may safely reduce the attack frequency of AECOPD, improve the symptoms of cough and chest stuffiness of stable COPD patients and increase life quality.